144 related articles for article (PubMed ID: 7696181)
1. Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver cells.
Liu J; Grove RI; Vestal RE
Cell Growth Differ; 1994 Dec; 5(12):1333-8. PubMed ID: 7696181
[TBL] [Abstract][Full Text] [Related]
2. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
[TBL] [Abstract][Full Text] [Related]
3. Induction of low density lipoprotein receptor (LDLR) transcription by oncostatin M is mediated by the extracellular signal-regulated kinase signaling pathway and the repeat 3 element of the LDLR promoter.
Li C; Kraemer FB; Ahlborn TE; Liu J
J Biol Chem; 1999 Mar; 274(10):6747-53. PubMed ID: 10037774
[TBL] [Abstract][Full Text] [Related]
4. Induction of Egr-1 by oncostatin M precedes up-regulation of low density lipoprotein receptors in HepG2 cells.
Liu J; Shoyab M; Grove RI
Cell Growth Differ; 1993 Jul; 4(7):611-6. PubMed ID: 8398902
[TBL] [Abstract][Full Text] [Related]
5. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro.
Richards CD; Brown TJ; Shoyab M; Baumann H; Gauldie J
J Immunol; 1992 Mar; 148(6):1731-6. PubMed ID: 1371787
[TBL] [Abstract][Full Text] [Related]
6. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
Mascaró C; Ortiz JA; Ramos MM; Haro D; Hegardt FG
Arch Biochem Biophys; 2000 Feb; 374(2):286-92. PubMed ID: 10666309
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
8. Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M.
Liu J; Streiff R; Zhang YL; Vestal RE; Spence MJ; Briggs MR
J Lipid Res; 1997 Oct; 38(10):2035-48. PubMed ID: 9374126
[TBL] [Abstract][Full Text] [Related]
9. Cell and tissue-type specific expression of Ras-related GTPase RhoB.
Fritz G; Gnad R; Kaina B
Anticancer Res; 1999; 19(3A):1681-8. PubMed ID: 10470101
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA
J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909
[TBL] [Abstract][Full Text] [Related]
11. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells.
Li C; Ahlborn TE; Tokita K; Boxer LM; Noda A; Liu J
Oncogene; 2001 Dec; 20(57):8193-202. PubMed ID: 11781835
[TBL] [Abstract][Full Text] [Related]
12. The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M.
Liu J; Li C; Ahlborn TE; Spence MJ; Meng L; Boxer LM
Cell Growth Differ; 1999 Oct; 10(10):677-83. PubMed ID: 10547071
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M-mediated transcriptional suppression of the c-myc gene in breast cancer cells.
Spence MJ; Vestal RE; Liu J
Cancer Res; 1997 Jun; 57(11):2223-8. PubMed ID: 9187125
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
15. Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: evidences of a human-specific signal transduction pathway for CYP1A1 induction.
Kikuchi H; Kato H; Mizuno M; Hossain A; Ikawa S; Miyazaki J; Watanabe M
Arch Biochem Biophys; 1996 Oct; 334(2):235-40. PubMed ID: 8900397
[TBL] [Abstract][Full Text] [Related]
16. Specific interaction of Egr1 and c/EBPbeta leads to the transcriptional activation of the human low density lipoprotein receptor gene.
Zhang F; Lin M; Abidi P; Thiel G; Liu J
J Biol Chem; 2003 Nov; 278(45):44246-54. PubMed ID: 12947119
[TBL] [Abstract][Full Text] [Related]
17. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells.
Sekar N; Veldhuis JD
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E128-35. PubMed ID: 14998783
[TBL] [Abstract][Full Text] [Related]
19. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
[TBL] [Abstract][Full Text] [Related]
20. Blockage of the ERK signaling pathway abrogates the SCAP ligand-induced transcriptional activation of the LDL receptor gene in HepG2 cells.
Abidi P; Zhang F; Li C; Liu J
Int J Mol Med; 2005 Nov; 16(5):779-85. PubMed ID: 16211244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
